Highlights
NASDAQ: INVA       Innoviva Inc
Last Price Today's Change   Day's Range   Trading Volume
14.43   -0.08 (0.55%)  14.35 - 14.69  394,800

Overview

 
Avg Volume (4 weeks):497,994
4 Weeks Range:13.66 - 14.69
4 Weeks Price Volatility (%):
74.76%
52 Weeks Range:10.03 - 20.54
52 Weeks Price Volatility (%):
41.86%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes RELVAR/BREO/ELLIPTA, ANORO, ELLIPTA, TRELEGY, ELLIPTA, and others. The firm collaborates with and receives funding from GlaxoSmithKline.

  Be the first to like this.
 


 

3414  4674  636  186 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers